Compare Align Technology, Inc. (ALGN) vs Synchrony Financial (SYF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Synchrony Financial — how do they compare? Align Technology, Inc. trades at $172.94 (market cap $12.29B), while Synchrony Financial trades at $78.75 (market cap $25.53B). The key difference: Synchrony Financial is far larger — about 2.1× Align Technology, Inc.'s market cap, and Synchrony Financial pays a 1.73% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | SYF | |
|---|---|---|
Market Cap | $12.29B | $25.53B |
Sector | Health | Financials |
52-Week High | $197.51 | $88.47 |
52-Week Low | $124.88 | $63.78 |
Enterprise Value | $11.30B | — |
Dividend Yield | — | 1.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $176.04, up 1.37% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported record Q2 2026 revenue of $1.06 billion, driven by strong clear aligner volume growth. Analyst sentiment is positive, with 73% recommending buy, and institutional activity shows mixed positioning amid strategic initiatives like board changes and patent wins in China.
The outlook remains favorable due to solid fundamentals and international expansion, but risks include competitive pressures in digital dentistry and reliance on North American market stability. Earnings growth and margin improvements are key catalysts, though valuation multiples near five-year lows suggest potential upside if execution continues.
Synchrony Financial (SYF) trades at $78.25, up 0.08% on the day, with a bullish technical outlook supported by moving averages and strong quarterly earnings beats. The stock shows robust fundamentals with a P/E of 8.05, net income margin of 23.4%, and consistent revenue around $15.0B. Recent news highlights partnerships like CareCredit with Stripe and aggressive share buybacks, while analyst consensus is strongly positive with a $86.33 price target.
The outlook for SYF is favorable due to undervaluation, earnings growth, and shareholder returns via dividends and buybacks. Risks include economic sensitivity to consumer spending and rising expenses. With no sell ratings from analysts and institutional confidence, the stock presents a solid opportunity for value-oriented investors seeking financial sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →
